Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009

    Insights

    A novel influenza A (H1N1) virus caused a global outbreak starting in Mexico and the US in 2009. Health organizations responded, and the World Health Organization (WHO) raised the pandemic alert to phase 5 due to human-to-human spread.

    Area of Science:

    • Public Health
    • Virology
    • Epidemiology

    Background:

    • An outbreak of novel influenza A (H1N1) virus emerged in Mexico and the United States in 2009.
    • The virus was confirmed by the CDC and Canadian health authorities.
    • Genetic analysis showed similarity between U.S. and Mexican influenza strains.

    Purpose of the Study:

    • To report on the initial investigations of the novel influenza A (H1N1) outbreak.
    • To provide an update on the global spread of the virus.
    • To document the public health response to the emerging pandemic.

    Main Methods:

    • Surveillance data compilation by WHO member states.
    • Case reporting and monitoring by the World Health Organization (WHO).
    • Genetic sequencing and comparison of influenza A (H1N1) strains.

    Main Results:

    • As of May 6, 2009, 1,882 confirmed cases were reported worldwide across 21 countries.
    • Human-to-human transmission was confirmed, leading to a WHO pandemic alert level increase to phase 5.
    • The novel influenza A (H1N1) virus demonstrated rapid international spread.

    Conclusions:

    • The novel influenza A (H1N1) virus represented a significant global public health threat in 2009.
    • International collaboration and surveillance were crucial for monitoring the outbreak.
    • The findings underscored the need for preparedness for novel influenza pandemics.

    Related Concept Videos

    Influenza01:27

    Influenza

    Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
    Infectious Diseases and Their Occurrence01:28

    Infectious Diseases and Their Occurrence

    Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
    Inhibitors Of Virion Release01:25

    Inhibitors Of Virion Release

    Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
    Viral Recombination00:57

    Viral Recombination

    Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
    Vaccinations01:51

    Vaccinations

    Overview
    Viral Mutations00:36

    Viral Mutations

    A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...